The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
Exactly Moniman. I am always surprised how little research some people do before investing.
Please read trader3's posts to get more informed.
And about to pay a substantial dividend....incredible opportunity for new investors to join the party.
Also topped up at 29.16p...absolute steal! Show me another £200m company with so much potential ...and about to pay a substanria
Any existing holders considering selling must have lost their marbles!! Today's RNS validates everything CF has been talking about for months. This is now a no risk/high reward investment ......expansion of the Challenge study model,a new global profile,immutex/prepbio,wearables,genomic database.....what's not to like? You show me a better place to be over the next year ,aimho
Human challenge study in Nov.. immutex sale December imho
Why do these bozos keep asking the same questions? You highlight the scenarios clearly,strictly. In the end,as long as you are invested now,just sit tight and see what actually happens.
Totally agree Leicester. Some posters appear to be financially illiterate. Any value extracted from the sale of assets,whether they are paid out as a dividend or not,comprise part of Orphs value. That doesn't seem to be too hard to comprehend,does it?
Your posts,DJ, indicate limited intelligence and elevated ego. DYOR imvho
I bow to your obvious longevity and may I add arrogance, deepjoy. How dare you tell me to dyor. You know nothing about me or my background. Before you criticise other posters valuations,it might be instructive to see your alternative valuation rather than making sarcastic comments.
I believe trader's potential valuation will be much nearer the mark than other doubting posters. He has the figures to substantiate it from CFs presentations. I don't see anyone else on here putting forward such a considered analysis.
Absolutely trader... Great work itemising the cupboard contents btw. If a bidding war for Orph does transpire,I have no doubt CF is aware of the value here. A few nice dividends from the non-core would be very welcome in the meantime.
Trader,you have amply demonstrated the value here for any doubters. This should be the investment of my lifetime if only some of the acorns grow into oak trees.
It would be dangerous to wait for a lower entry with news imminent. Do your research and assess the sum of the parts. Would it matter much anyway if you paid 23p instead of 20p when the potential here is so great?
Where is the stress with the human challenge contract announcement imminent and an Immutex dividend by xmas? By all means reduce at 50p if you are uncomfortable,but to sell before would be foolhardy AIMHO.
You have obviously done no research Dd77 to make such an assinine statement. I suggest you peddle your nonsense elsewhere.
Good point Swaple. Hence my view that after non-core bits sold and given to us as special dividends,the core business will be attractive to predators. Could big CROs like Icon or Iqvia be interested? The global Cro market is growly rapidly and expected to be worth 44bn dollars in 2021.
Always a risk trader,but I would hope CF is greedy enough not to let us go on the cheap. Fortunately he has a lot of money at stake. In the end us littl'uns must accept our fate.
And if a nice friendly pharma with deep pockets would like my shares for 500p now, I would happily sail off into sunnier climes and spend my millions. I wish.
How can a takeover approach be a risk? It would have to be at a huge premium to 20p current price. Would you not accept 100p within a few months for a 20p investment now? I know I would,though I think CF will sell non-core bits off piecemeal,and then maybe auction off our core business once human challenge trials have got going.